MedPath

Short Ragweed

ALLERGENIC EXTRACT Standardized Short Ragweed

Approved
Approval ID

1482f8a2-c2c0-45a1-8e90-b427227f0b28

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 18, 2019

Manufacturers
FDA

Allermed Laboratories, Inc.

DUNS: 073364531

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ambrosia artemisiifolia

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49643-315
Application NumberBLA103113
Product Classification
M
Marketing Category
C73585
G
Generic Name
Ambrosia artemisiifolia
Product Specifications
Route of AdministrationCUTANEOUS, SUBCUTANEOUS, INTRADERMAL
Effective DateSeptember 18, 2019
FDA Product Classification

INGREDIENTS (6)

SODIUM BICARBONATEInactive
Quantity: 0.125 g in 10 mL
Code: 8MDF5V39QO
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 0.25 g in 10 mL
Code: 451W47IQ8X
Classification: IACT
GLYCERINInactive
Quantity: 5.3 mL in 10 mL
Code: PDC6A3C0OX
Classification: IACT
AMBROSIA ARTEMISIIFOLIA POLLENActive
Quantity: 1 g in 10 mL
Code: K20Y81ACO3
Classification: ACTIB
PHENOLInactive
Quantity: 0.4 g in 10 mL
Code: 339NCG44TV
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Short Ragweed - FDA Drug Approval Details